Skip to content
Film Television Auditions – Lifestyle
Author:
Intryx Therapeutics
Intryx Therapeutics Receives IND Clearance of ITX-402 in Brain Neoplasms for a Phase 1/2a Pediatric Brain Tumor Trial
November 17, 2026